FB Nasdaq FB Facebook

Healthcares Week’s 20% Gainers: Chimerix Inc. (NASDAQ:CMRX), TESARO (NASDAQ:TSRO), Albany Molecular Research (NASDAQ:AMRI), Vanda Pharmaceuticals (NASDAQ:VNDA)

Chimerix Inc. (NASDAQ:CMRX) shares hit a new high on Thursday with the biotechnology firm continuing to get a boost from its decision to increase a test program for a virus-fighting drug so it can try to save a cruelly ill 7-year-old boy. Chimerix Inc. (NASDAQ:CMRX) stock performance was 2.80% in last session and finished the day at $27.14. Traded volume was 477,612.00 shares in the … Continue reading Healthcares Week’s 20% Gainers: Chimerix Inc. (NASDAQ:CMRX), TESARO (NASDAQ:TSRO), Albany Molecular Research (NASDAQ:AMRI), Vanda Pharmaceuticals (NASDAQ:VNDA)

John Bellich03/1703/17

FB Nasdaq FB Facebook

Biotech Most Volatile Stocks: Opexa Therapeutics (NASDAQ:OPXA), Intrexon (NYSE:XON), Chimerix (NASDAQ:CMRX), NewLink Genetics (NASDAQ:NLNK)

On March 5, 2014, Opexa Therapeutics, Inc. (NASDAQ:OPXA) entered into a First Amendment to Sales Agreement (the “First Amendment”) with Meyers Associates, L.P. (doing business as Brinson Patrick, a division of Meyers Associates, L.P.) (the “New Sales Manager”) and Brinson Patrick Securities Corporation (the “Original Sales Manager”). Pursuant to the First Amendment, the Sales Agreement dated September 6, 2012 by and between the Company and … Continue reading Biotech Most Volatile Stocks: Opexa Therapeutics (NASDAQ:OPXA), Intrexon (NYSE:XON), Chimerix (NASDAQ:CMRX), NewLink Genetics (NASDAQ:NLNK)

Colin Pettis03/1303/13

Investors Watch List : Mylan, Inc. (NASDAQ:MYL), Chimerix, Inc. (NASDAQ:CMRX), Universal Display Corp. (NASDAQ:OLED), Luxottica Group SpA (NYSE:LUX), Baytex Energy Corp. (NYSE:BTE)

Mylan, Inc. (NASDAQ:MYL) has become the target of anti-death penalty campaigners with a German investment fund selling its shares in the pharmaceuticals group because of concern that one of its products could be used in executions by American prisons. Mylan, Inc. (NASDAQ:MYL) belongs to Healthcare sector. Its net profit margin is 8.10% and weekly performance is 5.60%. On last trading day company shares ended up … Continue reading Investors Watch List : Mylan, Inc. (NASDAQ:MYL), Chimerix, Inc. (NASDAQ:CMRX), Universal Display Corp. (NASDAQ:OLED), Luxottica Group SpA (NYSE:LUX), Baytex Energy Corp. (NYSE:BTE)

Ryan Holtz10/21

Best Stocks : General Electric Company (NYSE:GE), J. C. Penney Company (NYSE:JCP), J&J Snack Foods Corp. (NASDAQ:JJSF), Chimerix, Inc. (NASDAQ:CMRX), Polycom (NASDAQ:PLCM)

Organization in focus has been General Electric Company (NYSE:GE), well-known as GE, and on being questioned by CNBC on its future prospects, vice president John Rice painted a rosy picture liberally doused with optimism. Much of his positive outlook was based on the fact that infrastructure as the company’s core business is likely to herald good things, especially when there are quite a few projects … Continue reading Best Stocks : General Electric Company (NYSE:GE), J. C. Penney Company (NYSE:JCP), J&J Snack Foods Corp. (NASDAQ:JJSF), Chimerix, Inc. (NASDAQ:CMRX), Polycom (NASDAQ:PLCM)

Colin Pettis09/19

Whats Hot Today : Agnico Eagle Mines (NYSE:AEM), Altair Nanotechnologies (NASDAQ:ALTI), Chimerix (NASDAQ:CMRX), Redwood Trust, Inc. (NYSE:RWT), Dril-Quip (NYSE:DRQ)

Agnico Eagle Mines Limited (NYSE:AEM) announced the filing of a technical report in respect of the Canadian Malartic mine. Agnico Eagle and Yamana Gold Inc (“Yamana”) each acquired a 50% interest in the mine as part of the joint acquisition of Osisko Mining Corporation, which was completed on June 16, 2014. The mine is operated by the Canadian Malartic GP under a joint management committee. Agnico Eagle Mines … Continue reading Whats Hot Today : Agnico Eagle Mines (NYSE:AEM), Altair Nanotechnologies (NASDAQ:ALTI), Chimerix (NASDAQ:CMRX), Redwood Trust, Inc. (NYSE:RWT), Dril-Quip (NYSE:DRQ)

Jayne Crisman08/21

Biotech Decliners: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Relypsa Inc (NASDAQ:RLYP), Receptos Inc (NASDAQ:RCPT), TG Therapeutics, Inc. (NASDAQ:TGTX), Chimerix Inc (NASDAQ:CMRX)

On May 9, 2014, Amicus Therapeutics, Inc. (NASDAQ:FOLD) updated its Investor Presentation for the Migalastat Monotherapy Program (the “Presentation”). The Company’s Chief Financial Officer, William D. Baird III and the Company’s Chief Operating Officer, Bradley L. Campbell, will present some or all of this Presentation to various investors in the coming months. A copy of the presentation materials is attached hereto as Exhibit 99.1. Amicus … Continue reading Biotech Decliners: Amicus Therapeutics, Inc. (NASDAQ:FOLD), Relypsa Inc (NASDAQ:RLYP), Receptos Inc (NASDAQ:RCPT), TG Therapeutics, Inc. (NASDAQ:TGTX), Chimerix Inc (NASDAQ:CMRX)

Jayne Crisman05/23